1. Home
  2. VCEL vs EFC Comparison

VCEL vs EFC Comparison

Compare VCEL & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$32.58

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

EFC

Ellington Financial Inc.

HOLD

Current Price

$11.96

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
EFC
Founded
1989
2007
Country
United States
United States
Employees
N/A
400
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
VCEL
EFC
Price
$32.58
$11.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$58.50
$14.55
AVG Volume (30 Days)
468.7K
1.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
13.22%
EPS Growth
60.00
N/A
EPS
0.32
N/A
Revenue
$276,259,000.00
N/A
Revenue This Year
$19.09
N/A
Revenue Next Year
$17.96
$52.40
P/E Ratio
$101.67
$9.50
Revenue Growth
16.45
N/A
52 Week Low
$29.24
$11.12
52 Week High
$48.75
$14.12

Technical Indicators

Market Signals
Indicator
VCEL
EFC
Relative Strength Index (RSI) 36.26 34.11
Support Level $31.34 $11.57
Resistance Level $38.48 $14.00
Average True Range (ATR) 1.42 0.27
MACD -0.31 -0.01
Stochastic Oscillator 20.52 34.36

Price Performance

Historical Comparison
VCEL
EFC

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: